Pharma Focus Asia

Repligen

LATEST NEWSRead more...

17

Jul 2024

Novo Holdings Leads $100 Million Series C Investment in Asceneuron to Advance Alzheimer's Therapy

Novo Holdings a prominent life science investor announced today it has spearheaded a million Series C financing round for Asceneuron a biotech company at the clinical stage focused on developing small

17

Jul 2024

FDA Grants Orphan Drug Status to 7MW3711

Mabwell an innovative biopharmaceutical company with a comprehensive industry chain recently announced that its selfdeveloped novel ADC targeting BH has received Orphan Drug Designation from the US Food and Drug Administration for the treatment of small cell lung cancer

17

Jul 2024

SK Biopharmaceuticals and Full-Life Technologies Announce Collaboration for New Therapy Targeting Multiple Solid Tumors

SK Biopharmaceuticals a prominent global biotech company has unveiled a substantial licensing agreement with FullLife Technologies a leading radiopharmaceutical company This deal valued at million

16

Jul 2024

Sabin Vaccine Institute Initiates Phase 2 Clinical Trial for Sudan Ebolavirus Vaccine

Sabin Vaccine Institute has launched a Phase clinical trial for its vaccine against Sudan ebolavirus at Makerere University Walter Reed Project in Uganda This strain of ebolavirus lacks approved vaccines and was involved in a recent outbreak that resulted in significant fatalities According to the...

16

Jul 2024

Argenx and Zai Lab Receive Approval for Efgartigimod Alfa Injection in China for Generalized Myasthenia Gravis

Argenx SE and Zai Lab Limited announced today that Chinas National Medical Products Administration has granted approval for the Biologics License

15

Jul 2024

Everest Medicines Announces Successful Phase 3 Trial Results for Etrasimod in Treating Moderately-to-Severely Active Ulcerative Colitis in Asia

Everest Medicines has announced positive results from the maintenance phase of a Phase clinical trial of etrasimod in Asia for moderatelytoseverely active ulcerative colitis

Solovpe

press releasesRead more...

17

Jul 2024

Biosyngen's BRG01 enters Phase II clinical trial, a first-in-kind autologous EBV-Specific CAR-T Therapy for Solid Tumors on Recurrent/Metastatic Nasopharyngeal Carcinoma

Biosyngen a leading biotechnology company focused on the development of innovative cell therapies recently announced that the Center for Drug Evaluation

17

Jul 2024

Sanyou Bio Collaborates on ADC Drug Development Entering Phase I Clinical Trials

Sanyou Biopharmaceuticals Co Ltd has recently announced a significant milestone in collaboration with Hangzhou Zhongmei Huadong Pharmaceutical Co Ltd

17

Jul 2024

Renalys Pharma Closes ¥6.0Bn Series A Financing to Advance Kidney Disease Treatments Across Asia

Renalys Pharma Inc a latestage clinical biopharmaceutical company has completed a Bn Series A financing The financing was led by Catalys Pacific and SR One along with additional investors

16

Jul 2024

Diakonos Oncology Receives FDA Fast Track Designation for Pancreatic Cancer Dendritic Cell Vaccine; Names Daniel D. Von Hoff, M.D. to Scientific Advisory Board

Diakonos Oncology Corporation a clinical stage immunooncology company announced today that the US Food and Drug Administration has granted Fast Track designation

16

Jul 2024

Acquisition of Amolyt Pharma completed

AstraZeneca today announced the successful completion of the acquisition of Amolyt Pharma a clinicalstage biotechnology company focused on developing novel treatments for rare endocrine diseases The acquisition bolsters the Alexion AstraZeneca Rare Disease latestage pipeline and expands on its bone...

15

Jul 2024

First Type 1 Diabetes Patient Enrolled in Rise Therapeutics' Latest Clinical Trial

Rise Therapeutics a clinicalstage biotechnology company developing novel oral immunotherapeutic medicines today announced that it has enrolled its first patient in its R placebo controlled blinded Phase b type diabetes clinical trial Gary Fanger President and Chief Executive Officer of Rise Therape...

30 - 01

Jul 2024

30 - 01

Jul 2024

chemical indonesia

jakarta barat, Indonesia

30 - 01

Jul 2024

Inalab 2023

Jakarta Barat, Indonesia

13 - 14

Aug 2024

ADVANCING BUSINESS, TECHNOLOGY AND INNOVATION

Songdo Convensia, Incheon, South Korea

13 - 14

Aug 2024

12 YEARS OF EXCELLENCE: SOUTH KOREA’S BIOLOGICS

Songdo Convensia, Incheon, South Korea

19 - 21

Aug 2024
MFA + MMA 2024
4th Annual Cleaning Validation 2024
2nd Annual Pharma Impurity Conclave 2024
CPHI Korea 2024
World Orphan Drug Congress Europe 2024
Thermo Fisher - Drug Discovery and the impact of mAbs

TOP ARTICLES

  • 1

    Artificial Intelligence

    Mansi Athalye

    Assistant Professor, Department of Pharmaceutics, L. M.College of Pharmacy

    Daryai Uma Ghanshyam

    L. M.College of Pharmacy

  • 3

    Homeopathic Science

    Aditya Dilipkumar Patil

    Assistant Professor, Department of Homoeopathic Pharmacy, Dr.D.Y.Patil Homoeopathic Medical College and Research Centre

    Parth Sanjeev Aphale

    Professor, Department of Homoeopathic Pharmacy, Dr. D Y Patil Homoeopathic Medical College and Research Centre

    Dharmendra Basudeo Sharma

    Principal, Dr. D Y Patil Homoeopathic Medical College and Research Centre

  • 5

    Multi-Target Directed Ligands and Lipidomics Approach for Glioblastoma Drug Discovery

    Dr. Stevan Pecic

    Department of Chemistry and Biochemistry, California State University, Fullerton, USA.

    Xiaohui Weng

    Department of Chemistry and Biochemistry, California State University, Fullerton, USA.

    Michael Gonzalez

    Department of Chemistry and Biochemistry, California State University, Fullerton, USA.

    Arya Emami

    Faculty of Dentistry, University of Toronto, Toronto, Canada.

    Dr. Amir Barzegar Behrooz

    College of Pharmacy, Rady Faculty of Health Sciences, University of Manitoba, Winnipewg, Manitoba, Canada.

    Dr. Rui Vitorino

    Department of Medical Sciences, Institute of Biomedicine-iBiMED, University of Aveiro, Aveiro, Portugal.

    Dr. Saeid Ghavami

    Research Institute of Oncology and Hematology, Cancer Care Manitoba, University of Manitoba, Winnipeg, Canada.

KNOWLEDGE BANK

  • Interviews

    Powder Systems Limited

    Tendering Manager Asia-Pacific

    Powder Systems Limited PSL has been exporting its technology to the AsiaPacific market since and a growing number of turnkey installations are to be commissioned in this region in the future To support the demand PSL has committed to further investment in AsiaPacific APAC by opening an engineering and sales office in Singapore This addition to PSL APAC will reinforce the fast growing activities c...
  • Articles

    Nanotechnology Strategies for Age –Related Macular Degeneration

    AMD accounts for the progressive deterioration of the Retinal Pigment Epithelium RPE function and loss of specialised neuroepithelial cells photoreceptors in the macula central part of the retina at the back of the eye responsible for central vision and therefore result in blurred and distorted vision Further it can cause irreversible blindness

  • Case Studies

    Analytics Stories: A Case Study from Quintiles

    As I have shared within other posts within this series businesses are using analytics to improve their internal and external facing business processes and to strengthen their right to win within the markets that they operate For pharmaceutical businesses strengthening the right to win begins and ends with the drug product development lifecycle I remember for example t...

  • Techno Trends

    Novel Phoenix® Therapy Developed to Treat PTSD

    Evren Technologies developed Phoenix a novel therapy for the treatment of Posttraumatic Stress Disorder PTSD The Phoenix is an earbud device which delivers a light electrical tingle to activate vagus nerve consisting of a calming effect on the body and also helps in reducing the symptoms of PTSD

  • White Papers

    RNA Therapeutics

    An exploration of a rapidly growing field in the biotech industry with the potential to revolutionise the treatment of a wide range of diseases

EDITORIAL SECTION